Publications by authors named "Benoit Van Hille"

Claim this Profile
A
Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare database.
Laurent Mortier, Astrid Blom, Benoît van Hille, Mahtab Samimi, Laura Luciani

Eur J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of highly active relapsing-remitting multiple sclerosis patients in the French national health insurance database.
Olivier Vandhuick, Marianne Payet, Emmanuelle Préaud, Joannie Lortet-Tieulent, Fanny Raguideau, Benoit van Hille

Expert Rev Pharmacoecon Outcomes Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Burden of the Out-of-Pocket Expenses for People with Multiple Sclerosis in France.
Olivier Heinzlef, Guillaume Molinier, Benoît van Hille, Lise Radoszycki, Paul Dourgnon

Pharmacoecon Open· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased nucleotide excision repair activity and alterations of topoisomerase IIalpha are associated with the in vivo resistance of a P388 leukemia subline to F11782, a novel catalytic inhibitor of topoisomerases I and II.
Anna Kruczynski, Jean-Marc Barret, Benoît Van Hille, Nathalie Chansard, Jackie Astruc

Clin Cancer Res· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis